Kathleen Kelley, MD
Dermatology · South Bend, INNPI 1245626225
Payments from drug & device makers
Across 128 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$751
- Johnson & Johnson$279
- Novartis$237
- Galderma Laboratories, L.p.$162
- Sanofi$144
- E.r. Squibb & Sons, L.L.C.$115
- plus $686 from 21 others
What the payments were for
- Food & beverage$2,16791%
- Education$2069%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $751 |
| Johnson & Johnson | 6 | $279 |
| Novartis | 13 | $237 |
| Galderma Laboratories, L.p. | 10 | $162 |
| Sanofi | 8 | $144 |
| E.r. Squibb & Sons, L.L.C. | 6 | $115 |
| Sun Pharmaceutical Industries Inc. | 5 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| Amgen | 3 | $73 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Dermavant Sciences, Inc. | 3 | $45 |
| Arcutis Biotherapeutics, Inc. | 3 | $43 |
| Smith+Nephew | 1 | $40 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $32 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Nobelpharma America, LLC | 1 | $23 |
| VYNE Pharmaceuticals Inc. | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| UCB, Inc. | 1 | $18 |
| LEO Pharma Inc. | 1 | $16 |
| Krystal Biotech Inc | 1 | $16 |
| Organon | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| EPI Health, LLC | 1 | $15 |
| Almirall LLC | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$2,374 in reported general payments places this provider in the 35th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 40 | $154,987 |
| Clobetasol Propionate | 113 | $4,525 |
| Tacrolimus | 30 | $4,379 |
| Fluorouracil | 41 | $3,750 |
| Ketoconazole | 132 | $2,372 |
| Doxycycline Monohydrate | 32 | $1,496 |
| Tretinoin | 11 | $1,197 |
| Triamcinolone Acetonide | 109 | $1,191 |
| Metronidazole | 22 | $995 |
| Clindamycin Phosphate | 16 | $718 |
| ValacyclovirValacyclovir Hcl | 21 | $573 |
| Hydroxychloroquine Sulfate | 13 | $567 |
| Betamethasone Dipropionate | 12 | $538 |
| Doxycycline Hyclate | 12 | $472 |
| Mometasone Furoate | 14 | $310 |
Paid to pharmacies, not to this prescriber.
Other dermatology in South Bend
- Holly Hake HarrisSouth Bend$3.4M
- Scott GuenthnerPlainfield$10.7M
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Megan LandisCorydon$2.8M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
- Vassilios DimitropoulosMichigan City$1.8M
- Christopher ObeimeIndianapolis$907K
- Megan VissingNew Albany$884K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.